{"filing":{"accession_number":"0001832511-26-000029","cik":"0001832511","ticker":"PIIIW","company_name":"P3 Health Partners Inc.","form":"8-K","filing_date":"2026-07-06","report_date":null,"primary_document":"piii-20260630.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000029/piii-20260630.htm"},"events":[{"id":16240,"run_id":14491,"accession_number":"0001832511-26-000029","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"summary":"P3 Health Partners amended an existing repurchase promissory note, extending its maturity to September 30, 2028, and modifying interest terms to accrue PIK (payment-in-kind) interest at 14% per annum. While this is technically an amendment to existing debt rather than a new issuance, it materially modifies the registrant's direct financial obligations by extending the repayment timeline and increasing the effective cost through PIK interest accrual. The 14% PIK rate and extended maturity are material modifications that would affect investor assessment of the company's debt obligations and liquidity.","company_name":"P3 Health Partners Inc.","ticker":"PIIIW","filing_date":"2026-07-06","form":"8-K","submitted_at":null,"items":[{"id":14281,"accession_number":"0001832511-26-000029","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"P3 Health Partners amended an existing repurchase promissory note, extending its maturity to September 30, 2028, and modifying interest terms to accrue PIK (payment-in-kind) interest at 14% per annum. While this is technically an amendment to existing debt rather than a new issuance, it materially modifies the registrant's direct financial obligations by extending the repayment timeline and increasing the effective cost through PIK interest accrual. The 14% PIK rate and extended maturity are material modifications that would affect investor assessment of the company's debt obligations and liquidity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T18:57:36.879342+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14281,"accession_number":"0001832511-26-000029","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"P3 Health Partners amended an existing repurchase promissory note, extending its maturity to September 30, 2028, and modifying interest terms to accrue PIK (payment-in-kind) interest at 14% per annum. While this is technically an amendment to existing debt rather than a new issuance, it materially modifies the registrant's direct financial obligations by extending the repayment timeline and increasing the effective cost through PIK interest accrual. The 14% PIK rate and extended maturity are material modifications that would affect investor assessment of the company's debt obligations and liquidity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T18:57:36.879342+00:00","company_name":"P3 Health Partners Inc.","ticker":"PIIIW","filing_date":"2026-07-06"}]}